Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study

Martin van den Bent; HK Gan; AB Lassman; P Kumthekar; R Merrell; N Butowski; Z Lwin; T Mikkelsen; LB Nabors; KP Papadopoulos; M Penas-Prado; J Simes; H Wheeler; T Walbert; AM Scott; E Gomez; H J Lee; L Roberts-Rapp; H (Hong) Xiong; E Bain; PJ Ansell; KD Holen; D Maag; DA Reardon

doi:10.1007/s00280-017-3451-1

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study

Martin van den Bent
, HK Gan
, AB Lassman
, P Kumthekar
, R Merrell
, N Butowski
, Z Lwin
, T Mikkelsen
, LB Nabors
, KP Papadopoulos
, M Penas-Prado
, J Simes
, H Wheeler
, T Walbert
, AM Scott
, E Gomez
, H J Lee
, L Roberts-Rapp
, H (Hong) Xiong
, E Bain

PJ Ansell, KD Holen, D Maag, DA Reardon

Neurology

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

117 Citations (Scopus)

36 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1209-1217
Number of pages	9
Journal	Cancer Chemotherapy & Pharmacology
Volume	80
Issue number	6
DOIs	https://doi.org/10.1007/s00280-017-3451-1
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1007/s00280-017-3451-1

REPUB_108611_OA.pdfFinal published version, 806 KB

http://hdl.handle.net/1765/108611

Cite this

van den Bent, M., Gan, HK., Lassman, AB., Kumthekar, P., Merrell, R., Butowski, N., Lwin, Z., Mikkelsen, T., Nabors, LB., Papadopoulos, KP., Penas-Prado, M., Simes, J., Wheeler, H., Walbert, T., Scott, AM., Gomez, E., Lee, H. J., Roberts-Rapp, L., Xiong, H., ... Reardon, DA. (2017). Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study. Cancer Chemotherapy & Pharmacology, 80(6), 1209-1217. https://doi.org/10.1007/s00280-017-3451-1

@article{56331a5812734e3399ef82ad4d488f64,

title = "Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study",

author = "\{van den Bent\}, Martin and HK Gan and AB Lassman and P Kumthekar and R Merrell and N Butowski and Z Lwin and T Mikkelsen and LB Nabors and KP Papadopoulos and M Penas-Prado and J Simes and H Wheeler and T Walbert and AM Scott and E Gomez and Lee, \{H J\} and L Roberts-Rapp and Xiong, \{H (Hong)\} and E Bain and PJ Ansell and KD Holen and D Maag and DA Reardon",

year = "2017",

doi = "10.1007/s00280-017-3451-1",

language = "Undefined/Unknown",

volume = "80",

pages = "1209--1217",

journal = "Cancer Chemotherapy \& Pharmacology",

issn = "0344-5704",

publisher = "Springer Science+Business Media",

number = "6",

}

van den Bent, M, Gan, HK, Lassman, AB, Kumthekar, P, Merrell, R, Butowski, N, Lwin, Z, Mikkelsen, T, Nabors, LB, Papadopoulos, KP, Penas-Prado, M, Simes, J, Wheeler, H, Walbert, T, Scott, AM, Gomez, E, Lee, HJ, Roberts-Rapp, L, Xiong, H, Bain, E, Ansell, PJ, Holen, KD, Maag, D & Reardon, DA 2017, 'Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study', Cancer Chemotherapy & Pharmacology, vol. 80, no. 6, pp. 1209-1217. https://doi.org/10.1007/s00280-017-3451-1

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study. / van den Bent, Martin; Gan, HK; Lassman, AB et al.
In: Cancer Chemotherapy & Pharmacology, Vol. 80, No. 6, 2017, p. 1209-1217.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study

AU - van den Bent, Martin

AU - Gan, HK

AU - Lassman, AB

AU - Kumthekar, P

AU - Merrell, R

AU - Butowski, N

AU - Lwin, Z

AU - Mikkelsen, T

AU - Nabors, LB

AU - Papadopoulos, KP

AU - Penas-Prado, M

AU - Simes, J

AU - Wheeler, H

AU - Walbert, T

AU - Scott, AM

AU - Gomez, E

AU - Lee, H J

AU - Roberts-Rapp, L

AU - Xiong, H (Hong)

AU - Bain, E

AU - Ansell, PJ

AU - Holen, KD

AU - Maag, D

AU - Reardon, DA

PY - 2017

Y1 - 2017

U2 - 10.1007/s00280-017-3451-1

DO - 10.1007/s00280-017-3451-1

M3 - Article

C2 - 29075855

SN - 0344-5704

VL - 80

SP - 1209

EP - 1217

JO - Cancer Chemotherapy & Pharmacology

JF - Cancer Chemotherapy & Pharmacology

IS - 6

ER -